riluzole
Selected indexed studies
- Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). (Cochrane Database Syst Rev, 2012) [PMID:22419278]
- The pharmacology and mechanism of action of riluzole. (Neurology, 1996) [PMID:8959995]
- Riluzole for the treatment of amyotrophic lateral sclerosis. (Neurodegener Dis Manag, 2020) [PMID:32847483]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). (2012) pubmed
- The pharmacology and mechanism of action of riluzole. (1996) pubmed
- Riluzole for the treatment of amyotrophic lateral sclerosis. (2020) pubmed
- A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. (1994) pubmed
- Riluzole. (2000) pubmed
- Riluzole: A neuroprotective drug with potential as a novel anti‑cancer agent (Review). (2021) pubmed
- Riluzole as a pharmacological therapy for spinal cord injury: where does this therapy stand? (2025) pubmed
- Riluzole, neuroprotection and amyotrophic lateral sclerosis. (2010) pubmed
- Riluzole promotes neurological function recovery and inhibits damage extension in rats following spinal cord injury: a meta-analysis and systematic review. (2019) pubmed
- Riluzole in psychiatry: a systematic review of the literature. (2008) pubmed